We found 7 mohs skin cancer surgeons who accept Humana Catastrophic HMO near New Orleans, LA.

Dr. Eric M Finley, MD
Specializes in MOHS-Micrographic Surgery
2820 Napoleon Avenue
New Orleans, LA
 

Dr. Eric Finley is a mohs skin cancer surgeon. His hospital/clinic affiliations include Ochsner and Touro Infirmary. He is a graduate of the University of Missouri-Columbia School of Medicine. Patients gave Dr. Finley an average rating of 3.5 stars out of 5. He is an in-network provider for Humana HMO, Humana Bronze, and Humana Catastrophic, as well as other insurance carriers.

Read more
Dr. Suneeta Singh Walia, MD
Specializes in MOHS-Micrographic Surgery
1514 Jefferson Highway
New Orleans, LA
 

Dr. Suneeta Walia sees patients in New Orleans, LA. Her medical specialty is MOHS-micrographic surgery. Humana HMO, Humana Bronze, and Humana Catastrophic are among the insurance carriers that Dr. Walia honors. She studied medicine at Louisiana State University School of Medicine in New Orleans. Dr. Walia's training includes a residency program at George Washington University Medical Center. She is professionally affiliated with Ochsner.

Read more
No Photo
Specializes in MOHS-Micrographic Surgery
1514 Jefferson Highway
New Orleans, LA
 

Dr. Peter Simoneaux's area of specialization is MOHS-micrographic surgery. He takes Humana HMO, Humana Bronze, and Humana Catastrophic, as well as other insurance carriers. Dr. Simoneaux attended medical school at Tulane University School of Medicine. He is professionally affiliated with Ochsner.

Read more
Dr. Zeena Jameel Al-Dujaili, MD
Specializes in MOHS-Micrographic Surgery
1415 Tulane Avenue; 5th Floor
New Orleans, LA
 

Dr. Zeena Al-Dujaili works as a mohs skin cancer surgeon. Clinical interests for Dr. Al-Dujaili include skin biopsy. She is affiliated with Tulane Medical Center. Before performing her residency at a hospital affiliated with Tulane University, Dr. Al-Dujaili attended Tulane University School of Medicine. She accepts Humana HMO, Humana Bronze, and Humana Catastrophic, in addition to other insurance carriers.

Read more

Clinical interests: Skin Biopsy

No Photo
Specializes in MOHS-Micrographic Surgery
1615 Metairie Road; Suite 101
Metairie, LA
 

Dr. Elizabeth Bucher is a physician who specializes in MOHS-micrographic surgery. Dr. Bucher speaks Spanish. She is professionally affiliated with UMass Memorial Medical Center. Her education and training includes medical school at Louisiana State University School of Medicine in New Orleans and residency at UMass Memorial Medical Center. Dr. Bucher is an in-network provider for Humana HMO, Humana Bronze, and Humana Catastrophic, as well as other insurance carriers. She has an open panel.

Read more
Dr. Diana Ngan Trieu, MD
Specializes in General Practice, MOHS-Micrographic Surgery
1415 Tulane Avenue; 4th Floor
New Orleans, LA
 

Dr. Diane Trieu works as a general practitioner and mohs skin cancer surgeon. She honors Humana HMO, Humana Bronze, Humana Catastrophic, and more. Dr. Trieu studied medicine at Tulane University School of Medicine. She is professionally affiliated with Tulane Medical Center.

Read more
No Photo
Specializes in MOHS-Micrographic Surgery
1615 Metairie Road; Suite 101
Metairie, LA
 

Dr. Keith Leblanc specializes in MOHS-micrographic surgery and practices in Metairie, LA. He is a graduate of Louisiana State University School of Medicine in New Orleans. Dr. Leblanc takes Humana HMO, Humana Bronze, Humana Catastrophic, and more.

Read more

Conditions / Treatments

Gender

Insurance

New Patients

Medicare Patient Age

Medicare Patient Conditions

Medicare Patient Ethnicity

Medicare Patient Insurance Eligibility

Additional Information

Distinctions

Foreign Language

Online Communication

Practice Affiliation

Certifications

Fellowship

Medical School

Residency

Years Since Graduation

What is MOHS-Micrographic Surgery?

Mohs micrographic surgery is a surgical treatment for skin cancer that was developed by Dr. Frederick Mohs in the 1930’s. It is the most effective technique for removing the most common types of skin cancer. For the two most common types of skin cancer, basal cell carcinoma and squamous cell carcinoma, Mohs has a 98-99% cure rate. The remarkable thing about Mohs is that it manages to be extremely good at removing all of the cancer cells while at the same time leaving behind most of the healthy tissue, so there is a smaller wound. This makes the procedure safer, speeds up the the recovery time, and minimizes scarring.

During Mohs surgery, skin around the cancer site is mapped out and removed in thin layers. Then each layer is examined under a microscope for cancer cells, while the surgery is in progress. If cancer cells are detected, the surgery continues and another layer is removed. If the skin is clear, the surgery can be stopped. This eliminates the guesswork for surgeons. There is no need to estimate the borders or roots of the cancer and no need to remove a margin of healthy tissue to ensure that all of the cancer is removed.

Even though Mohs has a high cure rate, is safer than other treatments, and takes less tissue, not every skin cancer is treated with Mohs. First, Mohs takes quite a bit longer than traditional surgery because each layer of skin must be carefully cut, prepped, and examined. It is also more expensive and may not always be covered by insurance. In addition, for smaller or less aggressive cancers that are easier to treat, the cure rate for non-Mohs treatments is close to that of Mohs; thus, the extra time and cost of Mohs might not be justified. Other kinds of skin cancer, such as melanoma, are hard to see under a microscope. Since melanoma is so dangerous, Mohs has traditionally not been used to treat it, as there is too much risk for missed cancer cells being left behind in the body. However, recent developments in stains (which make cancer cells more visible under a microscope) may change the role of Mohs in melanoma treatment.

Mohs microsurgery has changed the way doctors treat skin cancer in the past 80 years, and it continues to gain in popularity as it increases the effectiveness and safety of skin cancer treatment.